Tarsons Products IPO to open on November 15

The preliminary share sale of life sciences firm Tarsons will open for public subscription on November 15.
The three-day preliminary public providing (IPO) will conclude on November 17, in accordance with the pink herring prospectus (RHP).
The preliminary share sale contains recent issuance of fairness shares value Rs 150 crore and a proposal on the market of 1.32 crore fairness shares by promoters and an investor.
As part of the OFS, promoters — Sanjive Sehgal will offload as much as 3.9 lakh fairness shares and Rohan Sehgal will promote as much as 3.1 lakh fairness shares — and investor Clear Vision Investment Holdings Pte Ltd will divest as much as 1.25 crore fairness shares.

The public concern will embody a reservation for workers.
Proceeds from the recent concern will likely be utilised in the direction of paying debt, funding part of the capital expenditure for the brand new manufacturing facility at Panchla in West Bengal, and common company functions.
Tarsons Products is engaged in designing, creating, manufacturing and supplying a various vary of high quality lab-ware merchandise utilized in laboratories throughout analysis organisations, tutorial institutes, pharmaceutical companies, diagnostics firms and hospitals.
It manufactures a spread of high quality lab-ware merchandise that helps advance scientific discovery and enhance healthcare.

The firm at present function by its 5 manufacturing amenities situated in West Bengal.
ICICI Securities, Edelweiss Financial Services and SBI Capital Markets have been appointed as service provider bankers to advise the corporate on the IPO. The fairness shares will likely be listed on BSE and NSE.